MEDICLINIC SOUTHERN AFRICA
Mediclinic Southern Africa is a private hospital group operating in South Africa and Namibia focused on providing acute care, specialist-orientated, multi-disciplinary hospital services and related service offerings. We place science at the heart of our care process by striving to provide evidence-based care of the highest standard. The group currently operates 49 private hospitals (including 2 day clinics) throughout South Africa and 3 hospitals in Namibia with more than 8 000 beds in total.
Mediclinic Southern Africa is a wholly owned subsidiary of the international private healthcare group Mediclinic International plc, listed on the LSE (London Stock Exchange) with a secondary listing on the JSE (Johannesburg Stock Exchange) and the NSX (Namibian Stock Exchange). Mediclinic International currently has three operating divisions - Mediclinic Southern Africa which operates 52 private hospitals (including 2 day clinics) in South Africa and Namibia; Hirslanden operates 16 private acute care facilities and 3 clinics in Switzerland with more than 1 600 inpatient beds; and Mediclinic Middle East which operates 5 hospitals and 29 clinics with more than 600 inpatient beds in the United Arab Emirates. The group also holds a minority interest of 29.9% in Spire Healthcare Group plc, a leading private hospital group in the United Kingdom and also listed on the LSE.